Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Active, not recruiting · NCT02960087 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate carcinoma, prostate disorder | Active, not recruiting | Not applicable | 2026-04-22 | NCT02960087 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Cancer Trials Group | 73 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHUM-Centre Hospitalier de l'Universite de Montreal | Montreal | Canada | 20 |
| Hotel-Dieu de Quebec | Québec | Canada | 10 |
| London Health Sciences Centre Research Inc. | London | Canada | 13 |
| Odette Cancer Centre | Toronto | Canada | 20 |
| Ottawa Hospital Research Institute | Ottawa | Canada | 46 |
| The Jewish General Hospital | Montreal | Canada | 20 |
| University Health Network | Toronto | Canada | 52 |